221 related articles for article (PubMed ID: 28252278)
1. Bifunctional Succinylated ε-Polylysine-Coated Mesoporous Silica Nanoparticles for pH-Responsive and Intracellular Drug Delivery Targeting the Colon.
Nguyen CT; Webb RI; Lambert LK; Strounina E; Lee EC; Parat MO; McGuckin MA; Popat A; Cabot PJ; Ross BP
ACS Appl Mater Interfaces; 2017 Mar; 9(11):9470-9483. PubMed ID: 28252278
[TBL] [Abstract][Full Text] [Related]
2. Gated Mesoporous Silica Nanocarriers for a "Two-Step" Targeted System to Colonic Tissue.
González-Alvarez M; Coll C; Gonzalez-Alvarez I; Giménez C; Aznar E; Martínez-Bisbal MC; Lozoya-Agulló I; Bermejo M; Martínez-Máñez R; Sancenón F
Mol Pharm; 2017 Dec; 14(12):4442-4453. PubMed ID: 29064714
[TBL] [Abstract][Full Text] [Related]
3. A pH-sensitive silica nanoparticles for colon-specific delivery and controlled release of catechin: Optimization of loading efficiency and in vitro release kinetics.
Kassem AM; Almukainzi M; Faris TM; Ibrahim AH; Anwar W; Elbahwy IA; El-Gamal FR; Zidan MF; Akl MA; Abd-ElGawad AM; Elshamy AI; Elmowafy M
Eur J Pharm Sci; 2024 Jan; 192():106652. PubMed ID: 38008226
[TBL] [Abstract][Full Text] [Related]
4. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
5. Enzyme-responsive intracellular-controlled release using silica mesoporous nanoparticles capped with ε-poly-L-lysine.
Mondragón L; Mas N; Ferragud V; de la Torre C; Agostini A; Martínez-Máñez R; Sancenón F; Amorós P; Pérez-Payá E; Orzáez M
Chemistry; 2014 Apr; 20(18):5271-81. PubMed ID: 24700694
[TBL] [Abstract][Full Text] [Related]
6. pH-responsive poly (acrylic acid)-gated mesoporous silica and its application in oral colon targeted drug delivery for doxorubicin.
Tian B; Liu S; Wu S; Lu W; Wang D; Jin L; Hu B; Li K; Wang Z; Quan Z
Colloids Surf B Biointerfaces; 2017 Jun; 154():287-296. PubMed ID: 28351801
[TBL] [Abstract][Full Text] [Related]
7. Liquid CO
Raza A; Sime FB; Cabot PJ; Roberts JA; Falconer JR; Kumeria T; Popat A
ACS Biomater Sci Eng; 2021 May; 7(5):1836-1853. PubMed ID: 33438994
[TBL] [Abstract][Full Text] [Related]
8. pH - Responsive colloidal carriers assembled from β-lactoglobulin and Epsilon poly-L-lysine for oral drug delivery.
Pujara N; Giri R; Wong KY; Qu Z; Rewatkar P; Moniruzzaman M; Begun J; Ross BP; McGuckin M; Popat A
J Colloid Interface Sci; 2021 May; 589():45-55. PubMed ID: 33450459
[TBL] [Abstract][Full Text] [Related]
9. Preparation of end-capped pH-sensitive mesoporous silica nanocarriers for on-demand drug delivery.
Moreira AF; Gaspar VM; Costa EC; de Melo-Diogo D; Machado P; Paquete CM; Correia IJ
Eur J Pharm Biopharm; 2014 Nov; 88(3):1012-25. PubMed ID: 25229810
[TBL] [Abstract][Full Text] [Related]
10. Intracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells.
Zhou S; Wu D; Yin X; Jin X; Zhang X; Zheng S; Wang C; Liu Y
J Exp Clin Cancer Res; 2017 Feb; 36(1):24. PubMed ID: 28166836
[TBL] [Abstract][Full Text] [Related]
11. Intracellular pH-Triggered, Targeted Drug Delivery to Cancer Cells by Multifunctional Envelope-Type Mesoporous Silica Nanocontainers.
Yang K; Luo H; Zeng M; Jiang Y; Li J; Fu X
ACS Appl Mater Interfaces; 2015 Aug; 7(31):17399-407. PubMed ID: 26196506
[TBL] [Abstract][Full Text] [Related]
12. pH-Responsive Isoniazid-Loaded Nanoparticles Markedly Improve Tuberculosis Treatment in Mice.
Hwang AA; Lee BY; Clemens DL; Dillon BJ; Zink JI; Horwitz MA
Small; 2015 Oct; 11(38):5066-78. PubMed ID: 26193431
[TBL] [Abstract][Full Text] [Related]
13. Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles.
Clemens DL; Lee BY; Xue M; Thomas CR; Meng H; Ferris D; Nel AE; Zink JI; Horwitz MA
Antimicrob Agents Chemother; 2012 May; 56(5):2535-45. PubMed ID: 22354311
[TBL] [Abstract][Full Text] [Related]
14. A dual-responsive mesoporous silica nanoparticle for tumor-triggered targeting drug delivery.
Xiao D; Jia HZ; Zhang J; Liu CW; Zhuo RX; Zhang XZ
Small; 2014 Feb; 10(3):591-8. PubMed ID: 24106109
[TBL] [Abstract][Full Text] [Related]
15. Targeted modulation of cell differentiation in distinct regions of the gastrointestinal tract via oral administration of differently PEG-PEI functionalized mesoporous silica nanoparticles.
Desai D; Prabhakar N; Mamaeva V; Karaman DŞ; Lähdeniemi IA; Sahlgren C; Rosenholm JM; Toivola DM
Int J Nanomedicine; 2016; 11():299-313. PubMed ID: 26855569
[TBL] [Abstract][Full Text] [Related]
16. Gastro-protective protein-silica nanoparticles formulation for oral drug delivery: In vitro release, cytotoxicity and mitochondrial activity.
Juère E; Del Favero G; Masse F; Marko D; Popat A; Florek J; Caillard R; Kleitz F
Eur J Pharm Biopharm; 2020 Jun; 151():171-180. PubMed ID: 32302657
[TBL] [Abstract][Full Text] [Related]
17. Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers.
Feng W; Nie W; He C; Zhou X; Chen L; Qiu K; Wang W; Yin Z
ACS Appl Mater Interfaces; 2014 Jun; 6(11):8447-60. PubMed ID: 24745551
[TBL] [Abstract][Full Text] [Related]
18. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
19. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
[TBL] [Abstract][Full Text] [Related]
20. Mesoporous Silica Nanoparticles as pH-Responsive Carrier for the Immune-Activating Drug Resiquimod Enhance the Local Immune Response in Mice.
Wagner J; Gößl D; Ustyanovska N; Xiong M; Hauser D; Zhuzhgova O; Hočevar S; Taskoparan B; Poller L; Datz S; Engelke H; Daali Y; Bein T; Bourquin C
ACS Nano; 2021 Mar; 15(3):4450-4466. PubMed ID: 33648336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
